Publicaciones en colaboración con investigadoras/es de Hospital de Cruces (21)

2014

  1. Coregulation and modulation of NFκB-related genes in celiac disease: Uncovered aspects of gut mucosal inflammation

    Human Molecular Genetics, Vol. 23, Núm. 5

2013

  1. A novel form of human disease

    Prion Biology: Research and Advances (Apple Academic Press), pp. 179-210

2012

  1. UBQ-8i polymorphism is not an independent risk factor for mild cognitive impairment and Alzheimer's disease in APOE-4 carriers

    Current Alzheimer Research, Vol. 9, Núm. 4, pp. 467-472

2011

  1. Progression from amnesic mild cognitive impairment to alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene

    Dementia and Geriatric Cognitive Disorders, Vol. 32, Núm. 5, pp. 332-341

2010

  1. Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the α-synuclein gene (SNCA)

    Clinical Autonomic Research, Vol. 20, Núm. 4, pp. 267-269

2009

  1. Lrrk2 R1441G-related Parkinson's disease: Evidence of a common founding event in the seventh century in Northern Spain

    Neurogenetics, Vol. 10, Núm. 4, pp. 347-353

  2. The COMT Val158 met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers

    BMC Neuroscience, Vol. 10, pp. 125

2008

  1. Molecular evidence of founder effects of fatal familial insomnia through SNP haplotypes around the D178N mutation

    Neurogenetics, Vol. 9, Núm. 2, pp. 109-118

2007

  1. Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain

    Parkinsonism and Related Disorders, Vol. 13, Núm. 8, pp. 509-515

2006

  1. Fetal sex determination from maternal plasma by nested PCR of the amelogenin gene

    International Congress Series, Vol. 1288, pp. 691-693

  2. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEε3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease

    Dementia and Geriatric Cognitive Disorders, Vol. 21, Núm. 2, pp. 81-87

2005

  1. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease

    Neurology, Vol. 64, Núm. 9, pp. 1578-1585

  2. Ancestral origins of the prion protein gene D178N mutation in the Basque Country

    Human Genetics, Vol. 117, Núm. 1, pp. 61-69

2004

  1. High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma

    Journal of Viral Hepatitis, Vol. 11, Núm. 6, pp. 502-510

  2. Patterns of methylation profiles as diagnostic markers for multiple hepatocellular carcinomas

    Scandinavian Journal of Gastroenterology, Vol. 39, Núm. 3, pp. 246-251

  3. p14ARF gene alterations in human hepatocellular carcinoma

    European Journal of Gastroenterology and Hepatology, Vol. 16, Núm. 1, pp. 19-26

  4. p16INK4A Gene alterations are not a prognostic indicator for survival in patients with hepatocellular carcinoma undergoing curative hepatectomy

    Journal of Gastroenterology and Hepatology (Australia), Vol. 19, Núm. 4, pp. 397-405

2003

  1. 5-Hydroxytryptamine 6 receptor (5-HT6) receptor and apolipoprotein E (ApoE) polymorphisms in patients with Alzheimer's disease in the Basque Country

    Neuroscience Letters, Vol. 339, Núm. 1, pp. 85-87

  2. Frequent loss of p53 codon 72 Pro variant in hepatitis C virus-positive carriers with hepatocellular carcinoma

    Cancer Letters, Vol. 193, Núm. 2, pp. 199-205

  3. No association between GSTP1 gene aberrant promoter methylation and prognosis in surgically resected hepatocellular carcinoma patients from the Basque Country (Northern Spain)

    Liver International, Vol. 23, Núm. 4, pp. 249-254